Gayatri Balan
Pfizer (United States)(US)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Sulfur-Based Synthesis Techniques, Asymmetric Synthesis and Catalysis, Regulation of Appetite and Obesity, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Expedient Synthesis of Sulfinamides from Sulfonyl Chlorides(2006)111 cited
- → Discovery and Preclinical Characterization of 1-Methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1 H -pyrazolo-[3,4- b ]pyrazine (PF470): A Highly Potent, Selective, and Efficacious Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator(2014)51 cited
- → Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists(2009)51 cited
- → The discovery of novel calcium sensing receptor negative allosteric modulators(2009)41 cited
- → The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH)(2012)33 cited
- → Design and synthesis of potent, orally-active DGAT-1 inhibitors containing a dioxino[2,3-d]pyrimidine core(2011)22 cited
- → Metabolism-Guided Design of Short-Acting Calcium-Sensing Receptor Antagonists(2010)13 cited
- → Rational selection of structurally diverse natural product scaffolds with favorable ADME properties for drug discovery(2005)11 cited
- → Complementary α-alkylation approaches for a sterically hindered spiro[pyrazolopyranpiperidine]ketone(2012)11 cited
- → Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates(2017)9 cited